SEC Form 4 · accession 0001618835-18-000090
Evofem Biosciences, Inc. · EVFM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Alexander A Fitzpatrick
Officer — General Counsel and Secretary
Period of report
Aug 20, 2018
Accepted (ET)
Aug 21, 2018 · 4:06 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001618835
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 20, 2018 | P | 4,500 | $2.20 | A | 74,500 | D | |
| Common Stock | Aug 21, 2018 | P | 500 | $2.27 | A | 75,000 | D |
Table II — derivative securities
No Table II lines on this filing.